Fondaparinux and acute coronary syndromes: update on the OASIS 5&ndash;6 studies

Fondaparinux and acute coronary syndromes: update on the OASIS 5&ndash;6 studies

Fran&ccedil;ois SchieleDepartment of Cardiology, University Hospital Jean-Minjoz, Besan&ccedil;on, FranceAbstract: Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Four anticoagulant agents are currently commercially available for ACS, n...

Full description

Bibliographic Details
Main Author:	Fran&ccedil;ois Schiele
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-03-01
Series:	Vascular Health and Risk Management
Online Access:	http://www.dovepress.com/fondaparinux-and-acute-coronary-syndromes-update-on-the-oasis-5ndash6--a4142

Similar Items

FONDAPARINUX IN THE TREATMENT OF ACUTE CORONARY SYNDROME
by: O. O. Shakhmatova
Published: (2017-05-01)

FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
by: G. V. Mardaryan, et al.
Published: (2015-09-01)

Fondaparinux versus enoxaparin in the management of acute coronary syndromes in Switzerland
by: Michel Pierre Kossovsky, et al.
Published: (2012-03-01)

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data
by: Alexandre de Matos Soeiro, et al.
Published: (2016-01-01)

Fondaparinux
by: G. Airoldi, et al.
Published: (2013-05-01)

FONDAPARINUX IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION – JUSTIFICATION FOR USING AND REAL CLINICAL PRACTICE
by: A. D. Erlikh
Published: (2018-05-01)

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2017-05-01)

Custo-efetividade de fondaparinux em pacientes com Síndrome Coronariana Aguda sem supradesnivelamento do ST Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment Elevation
by: Camila Pepe, et al.
Published: (2012-07-01)

Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
by: Jean-Baptiste Bachet, et al.
Published: (2010-10-01)

Optimal management of cancer anorexia&ndash;cachexia syndrome
by: Josep M Argil&eacute;s, et al.
Published: (2010-01-01)

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
by: Alexander GG Turpie
Published: (2006-12-01)

Mycophenolic acid formulations in adult renal transplantation &ndash; update on efficacy and tolerability
by: D&eacute;la Golshayan, et al.
Published: (2009-04-01)

Evaluating the benefits of home-based peritoneal dialysis
by: François K, et al.
Published: (2014-12-01)

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor
by: Fabrizio Montecucco, et al.
Published: (2008-06-01)

Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India
by: Saumitra Ray, et al.
Published: (2023-04-01)

EARLY DISCONTINUATION OF FONDAPARINUX IN LOW-RISK PATIENTS HOSPITALIZED WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: MARKERS OF HEMOSTASIS ACTIVATION AND IN-HOSPITAL OUTCOMES
by: I. S. Yavelov, et al.
Published: (2015-03-01)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
by: Lindquist S, et al.
Published: (2011-05-01)

Current and emerging treatments for uterine myoma &ndash; an update
by: Duhan N
Published: (2011-08-01)

Treatment of Parkinson&#39;s disease: nanostructured sol&ndash;gel silica&ndash;dopamine reservoirs for controlled drug release in the central nervous system
by: Tessy L&oacute;pez, et al.
Published: (2010-12-01)

Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase
by: Mohamed S. Abdel-Bakky, et al.
Published: (2023-06-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

Fondaparinux Sodium: Recent Advances in the Management of Thrombosis
by: Rupert M. Bauersachs MD
Published: (2023-01-01)

Can this be considered a Fondaparinux-induced Thrombocytopenia?
by: Barbara Mariotti, et al.
Published: (2014-04-01)

Evidence-based decision-making within the context of globalization: A &ldquo;Why&ndash;What&ndash;How&rdquo; for leaders and managers of health care organizations
by: V&eacute;ronique Lapaige
Published: (2009-03-01)

Acute radiation syndrome (ARS) &ndash; treatment of the reduced host defense
by: Heslet L, et al.
Published: (2012-01-01)

Josef Jadassohn (1863&ndash;1936), Felix Lewandowsky (1879&ndash;1921), and their syndrome
by: Al Aboud A, et al.
Published: (2011-12-01)

Update and developments in the treatment of glioblastoma multiforme &ndash; focus on bevacizumab
by: Naveed Wagle, et al.
Published: (2010-06-01)

Amyotrophic lateral sclerosis: applications of stem cells &ndash; an update
by: Lidia Cova, et al.
Published: (2010-10-01)

Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
by: Francesco Marongiu, et al.
Published: (2020-10-01)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
by: Shimizu K, et al.
Published: (2018-02-01)

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders
by: Lensberg BR, et al.
Published: (2013-11-01)

An Application of Supertree Methods to Mammalian Mitogenomic Sequences
by: Véronique Campbell, et al.
Published: (2010-05-01)

Thought&ndash;shape fusion and body image in eating disorders
by: J&aacute;uregui-Lobera I, et al.
Published: (2012-10-01)

Second-Order Optimal Array Receivers for Synchronization of BPSK, MSK, and GMSK Signals Corrupted by Noncircular Interferences
by: Fran&#231;ois Delaveau, et al.
Published: (2007-01-01)

Association between Randall&rsquo;s plaque and calcifying nanoparticles
by: Neva &Ccedil;ift&ccedil;ioglu, et al.
Published: (2008-03-01)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
by: Fabricio Gonz&aacute;lez-Andrade, et al.
Published: (2010-07-01)

Nanocalcium-deficient hydroxyapatite&ndash;poly (&epsilon;-caprolactone)&ndash;polyethylene glycol&ndash;poly (&epsilon;-caprolactone) composite scaffolds
by: Wang Z, et al.
Published: (2012-07-01)

Volunteering in dementia care &ndash; a Norwegian phenomenological study
by: S&ouml;derhamn U, et al.
Published: (2012-02-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis
by: Kušić Jovana, et al.
Published: (2016-01-01)